Archives: Speakers

Paul is an experienced Clinical Supply Chain Professional with a 25-year career in the BioPharmaceutical industry.  His extensive career includes roles at major companies like Amgen and Thermo Fisher Scientific, where he honed his skills and made a significant impact.  He has served in varied roles from basic research and contract manufacturing to client services and account management.  He is a Principal Consultant and Co-Founder of Beacon BioPharm Associates, a clinical supply chain consulting firm, providing variable staffing solutions to small and mid-sized BioPharm clients.  Paul is an industry veteran and respected leader known for his expertise in clinical supply chain.

• Technology evangelist & adoption: Developed supply chain analytics and master data management Centers of Excellence to streamline data creation/maintenance/retirement, KPI dashboards, and data-driven decision-making.
• Organizational design: Implemented global supply chain, analytics, supplier quality, New Product Introduction (NPI), warehousing, e-Commerce, & Facilities teams to improve operational efficiencies and customer service.
• Supplier/supply chain performance, risk, compliance, and quality management: Lead adoption of ISO 13485:2016 and MDSAP in supply management (supplier lifecycle management, global audit program, CAPA, change management, quality agreements, CMO/OEM collaboration).
• Process development: Designed and deployed global supplier/supply chain risk assessment program focused on supplier risk profile, mitigation, and governance. Developed global standard supplier audit program and leveraged regional/in-country Lead Auditors. Designed CD/S&OP processes focused on balancing customer service, inventory, and operations efficiencies within FDA 21CFR Parts 820 & 210 regulated organizations.
• Strategic sourcing: Managed and lead various commodity-focused procurement teams including electro & electro- mechanical (instrument), biological & chemical (reagent and laboratory consumables), plastics & resin (injection molding), indirect (travel, fleet, facilities management, HR, IT, equipment, MRO, JanSan, critical Space) and partner/alliance operations (CMO/OEM) towards improved quality, cost, and total value.
• Entrepreneur: Principal and founder of the Biotech Supply Chain Academy (BSCA), which is dedicated to the education of professionals who serve the needs of patients, point-of-care healthcare organizations, and the Life Sciences industry. CEO and Founder of Mission City Consulting, which provides end-to-end supply chain and quality operations consulting, education, and advocacy in private industry, higher learning, and government.
• Educator and Mentor: Undergraduate and graduate school adjunct lecturer and faculty advisor at UC Davis Graduate School of Management, CSU Sacramento College of Business, Santa Clara University Leavey School of Business, the University of San Francisco School of Management, and Golden Gate University E.S. Ageno School of Business. Course work: Operations management & information systems, supply chain management, sustainable operations management, and MBA capstone integrated management operations.

Dr Mishra (Ex Genentech, Ex NCI, Ex NIH) is the founding president and CEO of the American Association for Precision Medicine ( and chair of ACT AAPM’s Coronavirus Taskforce He is leading research efforts focused on preventing curing chronic diseases not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives

He is also the founder and CEO of Agility Pharmaceuticals, a pharmaceutical company committed to revolutionizing drug discovery development through technology, big data, robotics, and artificial intelligence He is a serial entrepreneur who founded his first company after graduating high school, and his second company during his Ph D Since then, he has accumulated a wealth of experience by building, investing, and advising numerous other companies He is an investor, co founder/ board member of a few corporations, focused on accelerating drug discovery/ development, data analytics, robotics, mental health, and digital health He is also the founder of AAPM Angels and Investors AAi an investment group focused on investing in drug discovery, diagnostics, precision medicine, technology healthcare companies He is also the founding investor and advisor to Barcelona Ventures and serves as an advisor to a 100 M private equity fund

Widely recognized as a thought leader in the field of ‘technology and healthcare’, Dr Mishra has keynoted, chaired, curated, and organized numerous successful international conferences He served as a Scientist and Principal Investigator at the pharma giant Genentech, Roche Where he participated in several drug discovery project teams Moreover, his passion for drug development and precision medicine has led to the identification of new drug targets, biomarkers, companion diagnostics, and several drugs/ combinations in the clinic

His research work has been recognized globally by over 40 prestigious awards and honors Due to his unique perspective selfless service, he is a highly respected sought after mentor to many The companies that he has advised have raised multimillion dollars Notably, he serves as a mentor and advisor to several VC funds and startup accelerators, including IndieBio HIMSS/Health 2 0 ’s Project Zygote, MedLabs ZGC Capital, J&J JLabs UCSF Innovation Venture, UCSF Invent Fund, and California Life Sciences’s FAST program, to help grow California’s life sciences innovation ecosystem

Thiago Favano serves as Senior Director, Program Operations, leading MiNK’s clinical operations and portfolio strategy. Over 17 years of extensive experience across clinical development and operations, clinical research, market access, project management and strategic business projects on a global scale. with a remarkable ability to navigate complex regulatory landscapes and drive operational efficiency. He previously served as Senior Director of Clinical Development and Operations, and Senior Strategic Advisor for Orphan DC. He also served various positions in the Pharmaceutical industry, including Clinical Operations Consultant at Atea Pharmaceuticals, and roles at Alexion Pharmaceuticals. He is fluent in English, Spanish, French, and Portuguese, and received a PharmD and MBA from Universities in Brazil.

Paul Kong, leads Clinical Operation team within LaNova since Apr, 2021. He has more than 10 years experiences in CRO, such as Parexel and FMD, and then taking the leading role from various biotechs and big pharm, Roche, FibroGen, Hua Medicine and Alphamab in clinical operation team; and he has major contributions for lots of first in class production registration.

礼新医药临床运营副总裁。曾在精鼎、方恩等CRO公司任职并负责方恩临床运营工作，此后在罗氏以及珐博进、华领、康宁杰瑞等Biotech企业担任临床运营部门负责人，负责多项国际国内研究，并助力多项1.1类新药成功获批。